PFE – Pfizer Inc.

PFE — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

2.46

Margin Of Safety %

Put/Call OI Ratio

0.89

EPS Next Q Diff

0.1

EPS Last/This Y

1.59

EPS This/Next Y

-0.13

Price

25.78

Target Price

28.92

Analyst Recom

2.54

Performance Q

-4

Upside

-34.4%

Beta

0.3

Ticker: PFE

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-21	PFE	27.31	0.84	0.63	2332432
2026-04-22	PFE	26.8	0.84	0.57	2382647
2026-04-23	PFE	26.66	0.85	0.97	2421020
2026-04-24	PFE	27	0.87	0.29	2486142
2026-04-27	PFE	26.82	0.90	0.31	2425327
2026-04-28	PFE	26.47	0.88	0.49	2469325
2026-04-29	PFE	26.27	0.87	0.38	2535151
2026-04-30	PFE	26.7	0.87	0.46	2556853
2026-05-01	PFE	26.33	0.86	0.46	2570010
2026-05-04	PFE	26.33	0.88	0.43	2459559
2026-05-05	PFE	26.44	0.87	0.75	2528871
2026-05-06	PFE	26.5	0.90	0.43	2603107
2026-05-07	PFE	26.48	0.90	0.15	2623439
2026-05-08	PFE	25.67	0.91	0.94	2634331
2026-05-11	PFE	25.82	0.94	0.29	2573873
2026-05-12	PFE	25.89	0.93	0.31	2623789
2026-05-13	PFE	25.95	0.92	1.44	2643872
2026-05-14	PFE	25.75	0.94	0.59	2700525
2026-05-15	PFE	25.33	0.94	0.52	2718370
2026-05-18	PFE	25.32	0.93	0.66	2433493
2026-05-19	PFE	25.68	0.92	0.32	2482205
2026-05-20	PFE	25.78	0.89	0.28	2538994
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-21	PFE	27.32	-21.8	8591.5	2.96
2026-04-22	PFE	26.78	-21.8	8423.7	2.96
2026-04-23	PFE	26.66	-21.4	8623.7	2.96
2026-04-24	PFE	26.98	-21.4	8862.9	2.96
2026-04-27	PFE	26.81	-21.4	8597.9	2.96
2026-04-28	PFE	26.48	-21.4	8533.7	2.96
2026-04-30	PFE	26.70	-21.6	8934.6	2.96
2026-05-01	PFE	26.33	-21.6	8501.4	2.96
2026-05-04	PFE	26.31	-21.6	8687.1	2.96
2026-05-05	PFE	26.45	-21.6	8778.6	2.96
2026-05-06	PFE	26.50	-21.6	8724.7	2.96
2026-05-07	PFE	26.49	-12.8	8232.4	2.96
2026-05-08	PFE	25.67	-12.8	7825.0	2.96
2026-05-11	PFE	25.81	-12.3	8602.8	2.97
2026-05-13	PFE	25.96	-12.4	8347.8	2.97
2026-05-14	PFE	25.76	-12.4	8190.6	2.97
2026-05-15	PFE	25.32	-12.4	8064.4	2.97
2026-05-18	PFE	25.33	-12.6	8293.4	2.96
2026-05-19	PFE	25.69	-12.6	8497.7	2.96
2026-05-20	PFE	25.78	-12.8	8364.5	2.96
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-21	PFE	0.00	0.13	2.33
2026-04-22	PFE	0.00	0.13	2.33
2026-04-23	PFE	0.00	0.13	2.33
2026-04-24	PFE	0.00	0.13	2.33
2026-04-27	PFE	0.00	0.42	2.35
2026-04-28	PFE	0.00	0.42	2.35
2026-04-29	PFE	0.00	0.42	2.35
2026-04-30	PFE	0.00	0.42	2.35
2026-05-01	PFE	0.00	0.42	2.35
2026-05-04	PFE	0.00	0.11	2.35
2026-05-05	PFE	0.00	0.11	2.35
2026-05-06	PFE	0.00	0.11	2.35
2026-05-07	PFE	0.00	0.11	2.35
2026-05-08	PFE	0.00	0.11	0
2026-05-11	PFE	0.00	1.49	2.34
2026-05-12	PFE	0.00	1.49	2.46
2026-05-13	PFE	0.00	1.49	2.46
2026-05-14	PFE	0.00	1.49	2.46
2026-05-15	PFE	0.00	1.49	2.46
2026-05-18	PFE	0.00	1.09	2.46
2026-05-19	PFE	0.00	1.09	2.46
2026-05-20	PFE	0.00	1.09	2.46
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

0.75

Avg. EPS Est. Current Quarter

0.68

Avg. EPS Est. Next Quarter

0.85

Insider Transactions

Institutional Transactions

1.09

Beta

0.3

Average Sales Estimate Current Quarter

14410

Average Sales Estimate Next Quarter

16150

Fair Value

35.83

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

58.2

Max Drawdown 5-Year %

-59

Target Price

28.92

P/E

19.77

Forward P/E

9.1

PEG

P/S

2.32

P/B

1.63

P/Free Cash Flow

15.5

EPS

1.3

Average EPS Est. Cur. Y

2.96

EPS Next Y. (Est.)

2.84

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

11.79

Relative Volume

0.92

Return on Equity vs Sector %

-18.7

Return on Equity vs Industry %

-28.9

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

8364.5

◆ PFE Healthcare

$25.78

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

6/20

Pullback

19/25

Volume

7/15

Valuation

16/20

TP/AR

0/10

Options

4/10

RSI

41.9

Range 1M

29.8%

Sup Dist

1.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

3/30

Estimates

4/20

Inst/Vol

5/15

Options

7/10

EPS Yr

-8%

EPS NY

-4.4%

52W%

52.3%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟢 BUY +35.7% upside

Quality

10/30

Valuation

17/30

Growth

2/25

Stability

4/10

LT Trend

2/5

Upside

+35.7%

Quality

MoS

39%

Pfizer, Inc.

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 75000

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

PFE

Latest News

—

Caricamento notizie per PFE…

stock quote shares PFE – Pfizer Inc. Stock Price stock today

news today PFE – Pfizer Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch PFE – Pfizer Inc. yahoo finance google finance

stock history PFE – Pfizer Inc. invest stock market

stock prices PFE premarket after hours

ticker PFE fair value insiders trading

PFE – Pfizer Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: PFE

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y